Research Paper Volume 13, Issue 14 pp 18701—18717

Development and validation of a novel epigenetic-related prognostic signature and candidate drugs for patients with lung adenocarcinoma

class="figure-viewer-img"

Figure 12. Kaplan–Meier survival analysis is performed on the hub genes. (A) ARRB1, (B) PARP1, (C) PKM, (D) TFDP1, (E) YWHAZ.